ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO221

Merkel Cell Carcinoma Preceding Renal Primary Amyloidosis: Coincidence or Causality?

Session Information

Category: Onconephrology

  • 1700 Onconephrology

Authors

  • Saldanha Neves Horta Lima, Carolina, Mass General Brigham Salem Hospital, Salem, Massachusetts, United States
  • Rizkallah Alves, Beatriz, Mass General Brigham Salem Hospital, Salem, Massachusetts, United States
  • Burdge, Kelly A., Mass General Brigham Salem Hospital, Salem, Massachusetts, United States
Introduction

We present a rare association of Merkle Cell carcinoma and nephrotic syndrome.

Case Description

63-year-old female presented with new proteinuria and lower extremity swelling. She had recently taken 7 days of ibuprofen and amox/clav. She was initially started on furosemide, without improvement. Blood work revealed albumin of 2.3 g/dL and a 24h urine protein 4.35g. Her total cholesterol 449 mg/dL, LDL 319 mg/dL,triglycerides 274 mg/dL.
One month prior, she was diagnosed with non-metastatic Merkel cell carcinoma of her right thigh. Further workup revealed normal complements, negative ANCA, negatuve ANA. Kappa and lambda free light chains ratio of 6. SPEP showed hypoalbuminemia. A kidney biopsy dmeonstrated lambda light chain amyloidosis. Bone marrow biopsy identified lambda light chain restricted plasma cell population. Fluorescence in situ hybridization was negative for t(11;14). She was referred to oncology and started on chemotherapy.

Discussion

AL amyloidosis is characterized by the existence of a plasma cell clone in the bone marrow that secretes immunoglobulin light chains. Their deposition leads to variety of presentations, including nephrotic syndrome, restrictive cardiomyopathy, peripheral and autonomic neuropathy. Screening of end-organ involvement is crucial for early treatment due to severity of prognosis. AL amyloidosis is not infrequently related to hematologic malignancies, such as monoclonal gammopathy of undetermined significant and multiple myeloma.

Merkel cell carcinoma is a rare and aggressive cutaneous malignancy that affects older adults with light skin, especially in sun-exposed areas. Hematologic malignancies have been reported as a risk factor for Merkel cell carcinoma, most commonly chronic lymphocytic leukemia, more rarely multiple myeloma. Interestingly, patients with a preceding hematologic malignancy have a higher chance of being affected in an area not exposed to sun, such as our patient. This highlights 1) the non-coincidental occurrence of AL amyloidosis and an atypical presentation of Merkle cell carcinoma and 2) the need to further understand common physiopathological pathways. The question whether patients with an atypical Merkle cell carcinoma benefit from screening for hematologic malignancies remains.